Avian Virology Flashcards

1
Q

Pacheco’s DIsease is caused by what etiologic agent?

What is the family and subfamily of this virus?

What are the clinical signs associated with Pacheco’s disease?

Mucosal papillomas occur in what locations with this disease? What issues do those cause?

What species are particularly prone to papillomas?

What neoplasia is associated with mucosal papillomatosis?

A
  • Psittacid herpesvirus 1 (PsHV-1)
    • Alphaherpesviridae; genus Iltovirus – all avian herpes viruses are alphaherpesviruses.
      • Others in this group – mareks, columbrid alphaherpes 1.
    • Pacheco’s disease
      • Acute, rapidly fatal disease of parrots, some passerines
      • Mucosal papillomas and associated neoplasms of parrots
      • First recognized Brazil, late 1920s
      • Species affected and geographic distribution
        • Either sex, any age, all species susceptible
        • Mucosal papillomas greatest prevalence in Amazon parrots, macaws, Hawk-headed parrots, conures.
        • Documented in NA, Eu, Middle East, Japan, NZ, Aus.
      • Clinical signs
        • Unexpected death or multiple deaths over short period
        • Some birds may have biliverdin-stained urates (yellow or green) immediately prior to death
    • Mucosal papillomatosis
      • Cloaca, oral cavity
      • Some birds may exhibit upper resp signs, strain to defecate, have blood in droppings.
      • Generalized form of disease in the esophagus, crop, proventriculus, ventriculus – chronic wasting, regurgitation uncommon but may occur.
      • Papillomas cauliflower-like or cobblestone and diffuse.
      • Oral papillomatous lesions most common along margins of choanae and base of tongue.
      • Usually starts as loss of pigment prior to papilloma formation.
      • Lesions wax/wane, may disappear or progress.
      • Amazons, macaws, hawkheaded parrots, conures.
        • Evert cloaca during PE.
    • Bile duct and pancreatic duct carcinomas common sequelae to mucosal papillomatosis.
      • CS assoc with chronic liver disease – weight loss, overgrown beak, poor feather quality.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is Pacheco’s disease typically diagnosed?

What changes may be seen on bloodwork?

What lesions would be seen on gross and histology?

What are the inclusion bodies? What organ are they readily seen in?

What treatments are available? How efffective are they?

What is the incubation period for Pacheco’s disease?

Bile duct carcinomas are typically what genotype?

A
  • Diagnosis
    • Usually made at necropsy
    • Leukopenia, marked elevations in AST
    • Gross lesions variable.
      • Subtle liver changes that resemble diffuse lipidosis to prominent swelling, necrosis, pancreatitis, enteritis.
      • Most birds in good BCS.
      • Periportal hepatocytes typically spared
      • Pan-nuclear eosinophilic inclusions in liver and especially in spleen.
      • Pancreatic necrosis, necrosis of GIT with intralesional inclusion bodies.
      • Single report of cockatiel with chronic active pancreatitis secondary to PsHV1.
    • May have palpable crop thickening if diffuse papillomatosis.
    • Biopsy not necessary for diagnosis; PCR will return all these birds as positive, testing not necessary.
    • Rads may show rounded liver margins.
    • Bile duct carcinomas visualized on ultrasound.
      • Increased GGT with bile duct carcinomas, not specific.
      • Diagnosis confirmed by liver biopsy.
  • Treatment.
    • Acyclovir has been used in aviaries and individuals.
    • May be highly effective in preventing mortality during outbreaks.
    • Not cured, will become carriers.
      • Subclinical birds and survivors high risk for developing mucosal papillomas.
      • May lead to hepatic neoplasias/biliary carcinomas.
      • Cloacal carcinomas are rare.
    • Cases with mucosal papillomas are not impacted by treatment with acyclovir.
    • Mucosal papillomas should be left alone.
      • Can debulk with sharp dissection, laser surgery, radiosurgery, topical silver nitrate.
      • Repeated surgical intervention may result in cloacal scarring.
  • Epizootiology and preventive measures
    • Incubation 5-7 days.
    • Lifelong infections, future outbreaks.
    • When nonadapted parrots are exposed, Pacheco disease occurs.
      • Densely housed indoor collections are more prone to outbreaks of Pacheco disease.
      • All birds that developed bile duct and pancreatic duct carcinomas were tested as genotype 3.
    • PCR assays to detect all 4 genotypes of PsHV-1 have been developed.
    • Vaccines may prove useful in high-risk flocks.
    • Unkonwn if vaccination with one serotype will protect against others.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What species are commonly affected by Psittacine Herpesvirus 2?

What are teh clinical signs?

How is this disease diagnosed?

What treatments are available?

A
  • Psittacine herpesvirus 2 (PsHV-2)
    • Aphaherpesviriniae; genus Iltovirus.
      • Most closely related to PsHV-1 but not associated with Pacheco-like dz.
      • Species affected and geographic distribution
        • Only Congo African Grey Parrots in US and Germany
        • Only other bird known to be infected was a blue and gold macaw.
      • Clinical signs
        • Subclinical or mucosal and mucocutaneous papillomas of oral cavity and eye.
          • Benign but extensive.
          • Ddx include cutaneous papillomas by parrot papillomavirus 1 (PePV1), other oral neoplasias.
            • Rare, causes extensive face lesions, only reported in wild-caught birds.
      • Diagnosis
        • Gross lesions characteristic, can confirm by biopsy
        • Virus inclusions not reported
        • PCR to detect in tissue or oral/cloacal swabs
      • Treatment
        • No attempts have been made
        • Acyclovir is not effective – lesions not associated with replicated virus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical signs associated with Psittacine Herpesvirus 3?

How is this disease typically diagnosed?

What lesions are present on necropsy?

What histologic findings are typically seen?

What treatment and control measures are typically used?

A
  • Psittacine herpesvirus 3 (PsHV-3).
    • History and description of the virus
      • Alphaherpesvirinae; genus Iltovirus.
      • Occurs sporadically in a range of parrots in NA, Eu.
      • Targets trachea.
    • Species affected and geographic distribution
      • Only confirmed by sequencing an outbreak in Bourke’s parrots in US and two eclectus parrots in Aus.
      • Similar disease has been described in others.
    • Clinical signs
      • Coughing, difficulty breathing, ocular and nasal discharge.
      • Died within 3-7 days of signs.
      • Nonspecific clinical signs.
    • Diagnosis
      • Diagnosis in the live bird
        • No work has been done on diagnosis in live birds for PsHV3.
          • Cytology of conjunctiva and trachea has potential to detect syncytial cells and eosinophilic intranuclear inclusion bodies.
          • Can detect with panherpesvirus primers on PCR.
      • Postmortem diagnosis
        • Conjunctivitis, tracheitis, changes in lungs suggestive of diffuse or locally extensive pneumonia and air sacculitis.
        • Pale foci pancreatic necrosis.
        • Syncytial cells containing pan-nuclear eosinophilic inclusion bodies in bronchi, parabronchi, trachea, conjunctiva, air sac, respiratory epithelium of turbinates.
        • Numerous other tissues – spleen, pancreas, inner ear, meninges, kidney, thymus, bursa, gonads.
        • Lymphoplasmacytic inflammation, hyperplasia respiratory epithelium.
        • Unlike PsHV-1, liver is NOT primary target.
      • Treatment
        • Acyclovir may be helpful, unknown.
      • Epizootiology and preventive measures
        • Persistent infected birds likely to keep shedding.
        • Possible to detect subclinical carriers with PCR oral swabs, cloacal swabs, blood samples.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical signs of Columbid herpesivirus 1?

What types of pigeons are more commony affected?

How is this disease diagnosed?

What lesions are seen on necropsy?

How can it be treated?

A

COLUMBID HERPESVIRUS

Agent

· Columbid herpesvirus-1 (Smadel’s disease)

Demographics

· Pigeons – common in racing and fancier pigeon lofts more commonly than free-ranging pigeons

· If coinfected w/ circovirus: immunosuppression 🡪 clinical disease

Clinical manifestation

· Often subclinical

· More often clinical in squabs – lethargy, anorexia, weight loss, distended coelom

· Small, solid, grayish foci (sialiths) near choana

Diagnosis

· Antemortem

· Virus isolation

· Serology

· Postmortem

· Gross – hepatomegaly, splenomegaly

· Histo – necrotic foci in liver/spleen without inflammatory response; eosinophilic inclusion bodies

Treatment

· Acyclovir may be attempted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the three herpesviruses affecting raptorial birds?

How are these related to columbid herpesvirus 1?

What species is particularly susceptible?

What clinical signs are typically observed?

How is this diagnosed?

What lesions occur on necropsy? What are the inclusion bodies?

How can this be treaed and prevented?

A

RAPTOR HERPESVIRUSES

Agents

· Falconid herpesvirus-1 (FaHV-1)

· Strigid herpesvirus-1 (SHV-1)

· Accipitrid herpesvirus-1 (AHV-1)

Demographics

· Gyrfalcons appear particularly susceptible

Clinical manifestation

· Hepatosplenitis – multifocal necrosis of liver and spleen

· Signs – anorexia, lethargy, regurgitation, lime green urates, white plaques in the throat, unilateral keratitis/conjunctivitis, sudden death

Diagnosis

· Antemortem

· Virus isolation, serology

· Postmortem

· Gross – hepatomegaly, splenomegaly

· Histo – necrotic foci in liver/spleen without inflammatory response; eosinophilic inclusion bodies

Treatment

· Acyclovir may be attempted

Prevention

· Avoid feeding infected pigeons to raptors (main cause of infection)

FaHV-1 and SHV-1 are identical to columbid herpesvirus-1 (owls/falcons are aberrant hosts 🡪 severe disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Herpesviruses affect a wide range of avian species.

What are the clinical signs in the following groups?

Pigeons

Psittacines

Galliformes

Eagles

Falcons & Owls

Ducks

Cranes & Storks

Cormorants

Penguins

Toucans

Finch

Frigatebirds

A

Herpesvirus (MISC)

  • Etiology: Herpesvirus
  • Synonyms:
    • IBDF (falcons); owl herpes, pigeon herpes encephalo-myelitis, psittacine herpes
  • Geography: No. America, Middle East, Asia, Russia, Africa, Australia
  • Morbidity & Mortality: Varied
  • Seasonality: Unknown
  • Clinical Signs: Varied, see gross path
  • Pathology:
    • Chickens: Marek’s disease, infectious larnygotracheitis.
    • Pigeons and doves: encephalomyelitis.
    • Cranes and storks: hepatitis.
    • Quail and pheasant: hepatitis.
    • Songbirds: conjuctivitis.
    • Marine birds (cormorants (unknown)
  • Diagnosis: Viral isolation. Intranuclear inclusion bodies (Cowdry type A); serology to test for antibodies (likely a carrier)
  • Control: Isolation, depopulation
  • Human Issues: None
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the etiologic agent of Duck Plague?

What species are susceptible?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

A

Duck Plague

  • Etiology: Herpesvirus
  • Synonyms: Duck viral enteritis, DVE
  • Susceptible Species: Ducks, geese, swans. Blue winged teal redhead duck, wood duck highly susceptible. Least susceptible pintail duck.
  • Geography: No. America, Canada Netherlands, England. Atlantic flyways.
  • M/M: Mortality variable, 5-100%. Variation with species. May be variation with age and sex. Decreased egg production.
  • Seasonality: All year except Aug/Sep; late spring peak season.
  • Clinical Signs: Hypersensitive to light, extreme thirst bloody discharge from vent or bill, droopiness, penile prolapse, cold sore under tongue (think HERPES), inability to fly, convulsions
  • Pathology: GI hemorrhage; mallards: circum-scribed hemorrhagic band around intestine; goose: circular ulcers; ‘cheesy’ plaques in esophagus proventriculus, SI. Necrotic spots on liver. Heart=hemorrhagic areas
  • Diagnosis: Presumptive Dx on lesions. Viral isolation.
  • Control: Destroy entire flocks, including eggs b/c of inapparent carriers. Low virulence vaccine available (Pekin Duck). Not approved in other ducks and geese.
  • Other: Acute contagious fatal; inapparent infections. During latency, virus cannot be detected. Hardy-survives weeks. 4degC=water, 60d. Inactivated at pH< 3 and >1. Burn litter, chlorination helps. Sick birds dies: 3-7d after exposure. Wild birds-14d after exposure
  • Human Issues: None
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the etiologic agent of inclusion body disease of cranes?

What species are susceptible?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

A

Inclusion Body Disease of Cranes (IBDC)

  • Etiology: Herpesvirus
  • Synonym: Crane Herpes
  • Susceptible Species: Stanley, Sandhill, Manchurian, Hooded cranes most susceptible. Experimental infection to young Pekin & coots
  • Geography: U.S., Austria, France, China, Soviet Union, Japan
  • Morbidity & Mortality: UNK
  • Seasonality: Unknown
  • Clinical Signs: Lethargy, loss of appetite, death in 48 hours, sometimes bloody diarrhea
  • Pathology: Swollen livers and spleens. Pin-point to pinhead lesions (yellow-white) in tissue. Hemorrhage in thymus and intestines.
  • Diagnosis: Gross lesions. Viral isolation.
  • Control: Destroy entire flock. When not possible, isolate.
  • Other: Inapparent infections. Antibody response last for several years, unknown if exposed or carrier.
  • Human Issues: None
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of virus is Usutu Virus?

How is it transmitted?

What genus adn family does this virus belong to?

A
  • Usutu virus­
    • Mosquito-borne Flavivirus, African origin
      • Belongs to Japanese virus encephalitis group
      • Significant mortality European blackbirds, Vienna 2001
      • Emerging zoonotic potential – immunocompromised individuals
        • In healthy individuals may lead to skin rash or seroconversion
      • Some USUV naïve Strigiformes seem predisposed
        • Potential for spread to other than African or Eurasian continents is unknown
    • Taxonomy and description
      • Family Flaviviridae; genus flavivirus
        • ssRNA virus, icosahedral nucleocapsid
        • USUV polyprotein contains three structural proteins
          • Capsid protein (C)
          • Precursor membrane protein/membrane protein (PrM/M)
          • Envelope protein (E)
          • Seven nonstructural (NS) proteins
        • USUV is a member of the JEV serocomplex
          • Large scale bird mortality in naïve populations
          • Same group as WNV
    • Physical and chemical properties
      • Flaviviruses inactivated by drying, organic solvents, low pH, and proteases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the most susceptible species to Usutu virus?

What species have seroconverted without clinical signs?

What is the mosquito vector for this virus?

A
  • Biologic properties
    • Susceptible species
      • European blackbird (Turdus merula)
        • Most widely reported affected spp
      • Captive great gray owls (Strix nebulosa)
      • House sparrows in Switzerland
    • Seroconversion without clinical signs
      • Rock pigeons
      • Mallards
      • Magpies
    • Preference by the mosquito vector for certain hosp species.
      • Adult female Culex pipiens will seek certain avian hosts
        • Then virus replication and dissemination through infected saliva
        • Has been isolated from many spp of mosquitoes but vector significance is unknown.
        • Cx neavei from Senegal strongly suggested as vector for USUV.
          *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical signs associated with Usutu virus infection in birds?

What are the most common findings on necropsy?

What histologic findings are typically seen?

A
  • Clinical findings
    • Many avian spp show seroconversion without clinical signs
    • CS vary from nonspecific (immobility, ruffled plumage, eyes closed, anorexia) to neuro signs (depression, ataxia, jerky movements, torticollis, nystagmus, mortality).
    • Often goes unnoticed in humans.
    • From benign skin rash to neuroinvasive form.
  • Pathology
    • Peracute mortality, few obvious gross lesions
    • Splenomegaly, hepatomegaly, pulmonary hyperemia
    • Multifocal neuronal degeneration and perineuronal clustering of glial cells.
      • Cerebellar lesions may include degeneration of Purkinje cells, formation of glial shrubberies, lymphoplasmacytic perivascular cuffs, mild degeneration and necrosis.
      • Milliary pattern of liver necrosis, scattered myocardial necrosis.
      • IHC, potential for cross reactivity; ISH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is usutu virus diagnosed?

How do you expect serology to follow exposure?

What is teh gold standard?

How does USUV spread?

Where do most oubreaks occur? Why does urbanization favor outbreaks? Is there a seasonality to these outbreaks?

What is the key to preventing disease outbreaks?

A
  • Diagnostics
    • Serologic response follows viremia
      • Circulating IgM produced within 6 days followed by IgG.
      • Fourfold rise in titer beterrn acute and convalescent sera 10 days apart for acute infection.
      • False-positive possible
      • Acute mortality may not have enough time to seroconvert.
    • Initial screening – hemagglutination inhibition test (HIT).
      • Not specific.
      • Cross reacts with other flaviviruses.
      • More specific plaque reduction neutralization test (PRNT).
        • Considered gold standard for Flaviviridae, cross reactivity does occur.
        • Most reliable diagnosis is RT-PCR, USUV specific.
  • Epizootiology
    • USUV spreads in cycles between ornithophilic mosquito vectors and avian reservoir host.
      • Humans dead-end hosts.
      • May transmit arboviruses through blood transfusions.
        • Has been seen with WNV, not yet USUV.
      • Most European USUV epornitics have occurred in urban areas.
        • May enhance detection of new cases.
        • Urbanization favors the propagation of Cx. Pipiens by proliferation of artificial container habits.
          • Peak of mosquito reproductive season is between mid-July and mid-September.
  • Prophylaxis
    • Surveillance
      • Targeted, with special attention to blackbirds and house sparrows.
      • Rock pigeons and mallards.
    • Vaccination
      • No specific USUV vaccine
    • Mosquito prevention
      • Prevention of stagnant pools of water
      • Cyclopoid crustaceans or fish/terrapins can reduce larvae in pools or tanks.
      • Indoor housing of naïve Passeriformes and Strigiformes
      • Screens on windows and doors
      • Air conditioning
      • Humans should wear loose-fitting, long-sleeved clothes, stay indoors at dusk and dawn, use DEET.
      • Reduce the heat in urban areas i.e. shade trees, light-colored, highly reflective roof and paving materials.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the etiologic agent of Beak and Feather disease?

What psittacine species are susceptible?

What are the two forms?

What groups of psittacines may be super-distributors of the virus in Australasia?

How is this virus transmitted?

A
  • Psittacine beak and feather disease
    • Chronic, ultimately fatal virus of Psittaciformes
    • Acute form – nestling and fledglings
    • All parrots, lorikeets, cockatoos considered susceptible
      • Wild Australian parrots
      • Captive psittacine spp
    • Etiologic agent
      • Beak and feather disease virus (BFDV)
        • Family circoviridae
        • Hemagglutinating virus, agglutinates erythrocytes from GP, geese, many psittacines.
          • Unlike other circoviruses.
        • Ongoing massive viral excretion, readily detected with hemagglutination assay HA as an antigen detection diagnostic test.
    • Origins
      • 1907 South Australia; red-rumped grass parakeets
        • Aka French molt
        • Feather loss syndromes
        • All psittacine birds are susceptible to a diversity of BFDV clades, with no clear association based on host-virus cospeciation.
        • No one genotype is more virulent than another.
        • Loriinae subfamily – lorikeets, lories, budgies, may be most robust, super-distributors of the virus in Australasia.­
          • Do not have advanced feather and beak lesions, but may have some feather lesions.
          • Anecdotal evidence of complete recovery from infection.
    • Transmission
      • Excreted in feather dander and feces
      • High concentrations of virus can be detected in liver tissue, bile, crop secretions, feces, and feathers
      • Suspected to be transmitted vertically.
        • Can be found in embryos from infected hens.
        • Unlikely to be significant mechanism for circovirus maintenance.
      • Horizontal transmission, esp in Australia – tree nest hollows.
        • BFDV persists in the environment, high titers excreted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical signs associated with Psittacine Beak and Feather Disease?

How does the acute form manifest?

What about the chronic form?

In cockatoos, what is the first feather type that’s damaged? How does this appear clinically?

What are some sequelae to the damage caused by PBFD?

What changes on clinical pathology may be seen?

A
  • Clinical signs
    • Juvenile or young adult psittacine birds most susceptible to PBFD.
      • Acute form in nestlings and fledglings, esp Grey parrots.
        • Can die within a week of signs.
        • Rapid depression, leukopenia, anemia, green diarrhea, biliverdinuria, and death due to hepatic necrosis.
        • Systemic illness, anorexia or regurgitation.
        • Pterylodinia with edematous and painful wing tips, inflammation, vasculitis, SQ edema.
        • High viral tiers in liver and bile, may die of liver failure.
        • Affected feathers may shed all at once, or only primary feathers affected.
          • Usually seen in bilaterally symmetric pattern.
          • Fractures of developing calamus and intrapulp hemorrhage.
      • Chronic form, more common.
        • Slow subtle development and progression.
        • As molt progresses, dystrophic feathers replace normal.
        • Birds gradually lose plumage, often without other clinical signs of illness.
          • Usually bilaterally symmetric and slowly progressive.
        • Dystrophic feathers usually short, fault lines across vanes, thickened or retained feather sheath, blood within calamus, annular constriction of calamus, or curling.
    • In cacatuidae, powder down feathers aka pulviplumes, often first feathers affected.
      • Results in glossy/shiny or dark pseudodiscoloration of beak and claws.
      • Plumage may become dull.
        • PBFD-affected pulviplumes fragile or develop abnormally thickened outer sheath that fails to disintegrate.
        • Beak may also develop fracture lines/slough.
      • Sunlight-exposed skin may become darkly pigmented.
      • Chronic ulcers at elbows and wing tips.
      • Predisposed to hypothermia, secondary infections from immunosuppression.
        • Most chronic cases lead to difficulty eating, weight loss, death.
        • Some spp, feathers falling out may be only clinical sign.
        • First clinical sign in birds with green plumage may be development of yellow feathers.
        • Beak abnormalities happen LATE in disease.
    • Clinical pathology
      • Acute – severe leukopenia in juvenile birds
      • Chronic – lower serum protein concentrations, low prealbumin and gammaglobulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Psittacine beak and feather disease virus produces what histologic lesions?

What are the inclusion bodies?

For IHC, what are the best organs to test?

What is the most common lesion in African grays?

How is BFD diagnosed? What is the gold standard?

How is this treated?

What species are likely to make a full recovery?

How is this disease prevented?

A
  • Histopathology
    • Multifocal epithelial cell necrosis, necrosis distal feather shafts, epidermal hyperplasia and hyperkeratosis.
    • Basophilic intracytoplasmic inclusions within macrophages in the feather pulp.
    • Some epithelial keratinocytes may contain intracytoplasmic or intranuclear inclusions.
    • Liver may be congested.
      • Basophilic inclusions within Kupffer cells of liver.
      • Focal aggregates of necrotic lymphocytes often contain MP with typical inclusions.
      • Inclusion bodies arranged in a paracrystalline array.
    • IHC, ISH can be used.
      • Best organs to assess are bursa of Fab, feather follicles, spleen, esophagus, and crop.
    • Severe lymphoid depletion in African grays more common than feather lesions in that spp.
  • Dx
    • Chronic – PE.
      • Ddx hypothyroidism for bilateral feather loss.
      • Australia – serology and antigen detection
      • Hemagglutination inhibition HI remains the gold standard for antibody detection.
      • PCR.
        • Collection of bodily tissues i.e. blood.
        • False-positive is possible, but rare.
          • To avoid this:
          • Test can be repeated using second round of DNA extraction from original sample.
          • Separate PCR test for different part of the viral genome can be used.
          • DNA sequencing can be done on the amplicons and compared with positive controls.
          • Retest at 90 days.
        • False negatives from leukopenia.
  • Tx
    • Many make full recoveries – lorikeets and eclectus parrots.
    • Mostly supportive care.
    • Interferon alpha modulatory CpG sequences have been described in other circoviruses.
      • Both inhibitory and stimulatory effects on induction of IFN alpha, inhibition of TNF alpha.
      • Cytokines show promise for treatment.
      • Older therapy, not really used anymore.
  • Prevention and control
    • Disinfection with Virkon S
    • Strict quarantine and screening of new additions to flock
    • No commercially available vaccine for BFDV.
17
Q

What is the etiologic agent of Budgerigar Fledgling Disease?

What are the clinical signs?

What is teh mortality of this virus?

How is it transmitted?

A
  • Avian polyomavirus
    • APyV-1 formerly known as budgerigar fledgling disease virus.
      • dsDNA virus
      • Polyomaviridae, genus Gammapolyomavirus
      • Icosahedral, nonenveloped
      • Causes hepatitis, ascites, hydropericardium, depression, feather disorders over abdomen and back, abdominal distension, hepatomegaly, pericardial effusion, renomegaly.
      • Mortality may reach 100% esp in fledglings.
      • Shedding in feather, skin, feces during first 6 mos of infection.
        • Then viral concentration in tissues decreases and shedding ends with beginning of sexual maturity and breeding activity.
18
Q

What is the etiologic agent of Fowl Pox?

What species are susceptible?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

A

Avian Pox

  • Etiology: Poxvirus. Vector: mosquito.
  • Synonym: Fowl pox, avian diphtheria, contagious epithelioma, poxvirus infection
  • Susceptible Species: All. Hawaiian forest birds: incr vectors because of mountain craters and global warming.
  • Geography: Worldwide
  • Morbidity & Mortality: Mortality is low. In canaries, quail and pigeons high mortality (canarypox) reach 100% in infected canaries
  • Seasonality: Year-round, mostly associated with emergence of vectors though
  • Clinical Signs: Wart-like nodules on featherless areas (feet, legs, base of beak, eye margin. Weak if interferes with feeding). Exotic birds typically get one BIG nodule, domestics get numerous. Nodules can occlude resp tract.
    • 2 forms: cutaneous and wet (internal).
    • Cutaneous: warty nodules, secondary infections and effects.
    • Wet: diphtheritic-moist necrotic lesions on mucous membranes (mouth, upper GI)
  • Pathology: Gross lesions. Microscopic lesions: cellular inclusion bodies. Viral isolation. Serology. Impression smears= Bollinger bodies (look like balls)
  • Control: Vector control, environmental decontamination. Modified live vaccine for poultry, 5% bleach for decontamination
  • Human Issues: No evidence of zoonosis, but there are human lesions that are similar
19
Q

What is the etiologic agent of Eastern Equine Encephalomyelitis in birds?

What species are susceptible? What is unique about the presentation in emus?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

A

Eastern Equine Encephalomyelitis (EEE)

  • Etiology: EEE, eastern encephalitis, EE, eastern sleeping sickness of horses
  • Taxonomy: Togavirus, RNA virus
  • Susceptible Species: Ibis, pigeon, sparrow. Pheasant, partridge, duck, emu. Emu=enteritis (EEEEE) other birds WEE= neuro
  • Geography: No. America, Central and So. America.
  • Morbidity & Mortality: 65% morb, 80% mort
  • Seasonality: Early summer (vector emergence).
  • Clinical Signs: No signs in native species of bird. Pheasant: lethargy. Depression, leg paralysis, profuse diarrhea, voice changes, ataxia, other neuro.
  • Pathology: Ascites, intestinal mucosal discoloration, fat depletion, hepatomegaly, splenomegaly, visceral gout.
  • Diagnosis: Viral isolation (blood, brain) neutralizing antibodies in serum.
  • Control: Decrease vector populations. Vaccination, killed virus.
  • Human Issues: Susceptible: aerosol possible but rare.
20
Q

What is the etiologic agent of Newcastle Disease?

What are the three strains of this virus?

What species are susceptible?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

How long is the incubation period?

Are there any human health issues?

A

Newcastle Disease

  • Etiology: Paramyxovirus group 1 RNA virus.
    • VVND (viscerotropic velogenic Newcastle disease)
    • NVND (neurotropic velogenic Newcastle disease)
    • mesogenic
    • lentogenic
  • Synonyms: ND, paramyxo-virus-1, NDV, VVND, NVND,
  • Susceptible Species: Poultry, cormorants (yearly), pelicans. Gulls, mallard (esp ducklings)
  • Geography: Global
  • Morbidity & Mortality: Mort: 100% can occur with VVND. NVND morb 100% mort 50%. Mesogenic-moderate: neuro/death in chicks. Lentogenic: resp dz in chicks, GI inapparent too
  • Seasonality: March-sept in cormorants.
  • Clinical Signs: Torticollis. Ataxia, tremors, paresis, unilateral or bilateral paralysis legs and wings, clenched toes.
  • Pathology: Non-specific. Spleens.liver larger and mottled but not most.
  • Diagnosis: Viral isolation
  • Control: Reportable disease-contact authorities. 2-15 days, average 5-6 days. Exp: onset 2d after inoculation.4d to torticollis.
  • Human Issues: Self limiting conjuctivitis or inflammation of nictitans, mild flu-like disease. Aerosol transmission
21
Q

What is the etiologic agent of Woodcock Reovirus?

What species are susceptible?

Where is this disease found naturally?

What is the morbidity and mortality?

Is there a seasonality to this disease in the wild?

What are the clinical signs?

What are the findings on pathology?

How is this diagnosed?

How is it controlled?

How long is the incubation period?

Are there any human health issues?

A

Woodcock Reovirus

  • Etiology: Reovirus
  • Susceptible Species: Woodcock, unknown about other species
  • Geography: SE U.S.
  • M&M: UNK
  • Seasonality: Winter: 2 die-offs 1989-90, 1993-4
  • Clinical Signs: None observed; animals were found dead
  • Pathology: No gross lesions. Histopath: arthritis/tenosynovitis, growth retardation, pericarditis, myocarditis, enteritis, hepatitis, bursal atrophy, osteoporosis, respiratory syndromes
  • Diagnosis: Viral isolation: cloacal swabs, intestines.
  • Control: UNK
  • Human Issues: None likely
22
Q

What is proventricular dilatation disease?

What is the associated inflammation - what structures does that surround?

What are the clinical signs?

Is there an age predilection?

A

Avian Bornavirus and Proventricular Dilation Disease

  • Common and fatal disease in birds that affects primarily psittacines
  • Proventricular dilation disease
  • First seen in 1970s and named Macaw wasting disease
  • Seen in >60 species
  • Characterized by nonpurulent inflammation of the peripheral nerves (autonomic nervous system of GI tract)
  • Clinical signs: lethargy, weakness, ruffled feathers, often with normal appetite. Weight loss, maldigestion, vomiting seen later. CNS signs include ataxia, lameness, tremor, seizures (can be seen without GI disease)
  • No age predilection (mean: 3.8 years)
  • Ddx: Candida, Macrorhabdus, bacterial/parasitic infections, neoplasia, FB, lead/zinc toxicity
  • Dilated proventriculus typically thin with slow contrast passage time
  • Histo of proventriculus reveals lymphoplasmacytic infiltrations on ganglia (typically post-mortem, can try crop biopsy)
  • 24% crop biopsies have false negative results – no longer a valuable tool
  • Treatment
  • Provide highly digestible, high energy diet
  • Metoclopramide symptomatically
  • Antibiotic/antifungal at beginning of therapy
  • NSAIDs appears to have most beneficial effects, reducing speed of progression
23
Q

What is the etiologic agent of proventricular dilatation disease?

What mammalian bornaviruses exist?

What are the various avian bornaviruses that exist?

How prevalent is avian bornavirus?

A

Avian Bornavirus

  • Detected in 2008 from PDD-affected birds
  • Order Mononegavirales – includes paramyxoviridae, rhabdoviridae, filoviridae
  • Large, enveloped virus with ssRNA
  • Unlike other families in the order, uses cellular gene-splicing machinery for protein expression and replication
  • Genome highly conserved, only two genotypes described of Borna disease virus
  • Mammalian: BDV-1, BVD-2, new squirrel Bornavirus with possible zoonotic potential
  • Avian: 8 genotypes of ABV, 7 from non-psittacines
  • Replicates poorly in mammalian cells (BDV replicates in both)
  • Psittaciform 1 bornavirus: ABV 1, 2, 3, 4, 7 AKA PaBV1-7), new virus PaBV-8 found in Brazil
  • Passeriform 1 bornavirus (C1, C2, C3, LS AKA canary CnBV 1-3), Waterbird 1 bornavirus (062CG), passeriform 2 bornavirus.
  • ABV5 and 6, MALL, and reptile bornaviruses remain unassigned
  • Embedded in avian genomes in low copy number
  • ABV as the cause of PDD
  • Causative role and infection trials confirmed ABV as cause – though complicated by presence of other viruses in experimental population
  • Superinfection may be possible with 2 different strains
  • Occurrence of Avian Bornavirus
  • Worldwide occurrence, prevalence studies rare
  • 22.8% in Europe, 32.2% in one flock, 4.3% in Japan
  • ABV-positive, non-clinical birds common
  • Detected ABV-4 in free-ranging birds
  • 0-13% prevalence in free-ranging water birds
  • ABV-2 and 4 most common in psittacines
24
Q

How is avian bornavirus transmitted?

Is it vertically transmitted?

Describe the pathogenesis of this virus.

A
  • ABV Transmission
  • Fecal-oral presumed due to detection on cloacal-crop swabs
  • Horizontal transmission by direct contact insufficient in immunocompromised fully-fledged canaries/cockatiels
  • No seroconversion noted in cockatiels infected orally, intranasally – need for mucosal injury?
  • Grey parrots infected SQ
  • Vertical transmission possible, but not proven
  • Embryos positive for RNA from ABV positive psittacine parents, but negative offspring possible
  • No PDD seen in inoculated cockatiel embryos
  • Route of transmission not fully understood
  • Potential pathogenesis
  • Circumstances leading to clinical infection not understood
  • Parallels BDV, though varies (IV inoculation did not work in rats)
  • Possible immune-mediated pathogenesis (similar to Guillain-Barre)
  • Disease induced through mechanisms independent of viral load and earlier activation of immune system causes more severe disease
25
Q

How is avian bornavirus diagnosed?

What tests are available? What are some downsides to each?

How do affected birds present clinically?

What inflammation is present around the enteric ganglia?

How does ABV variant affect clinical course?

How should positive serology or PCR be used to establish whether a bird is positive?

A
  • Diagnosis
  • RNA RT-PCR of cloaca, crop, fecal swabs, feather calamus, or blood (Combined crop/cloacal swab ideal)
  • For negative, but suggestive cases, further protocols should be applied
  • False negative, no active shedding
  • ABV detection is specific task that requires experience
  • Place in cool environment or transport media
  • IHC can detect ABV antigen in tissues
  • Limited use in daily practice
  • Viral isolation
  • False negative common
  • Not ideal for daily practice
  • Serology
  • Can have shedders without seroconversion
  • Titer may correlate with possibility of developing clinical signs
  • ELISA, Western blot
  • Clinical disease of avian bornavirus and disease patterns
  • Lymphoplasmacytic infiltration in ganglia, PDD
  • CNS signs: tremor, seizures, ataxia, head-shaking, opisthotonos
  • ABV seen in 50% of birds with FDB can be seen, though shedding/antibodies low
  • Quality and quantity of clinical signs depends on ABV variant and host factors
  • ABV-2 > ABV-4
  • Clinical signs in 22 days – 20 months
  • 3 clinical courses of ABV-2
  • Severe, acute symptoms right after infection
  • Mild course about 80 days after infection
  • Late infection (172 days) with mild progression or no signs
  • Clinical diagnosis of Avian Bornavirus Infection
  • Direct and indirect tests needed, particularly to distinguish carriers from shedders
  • If PCR and serology positive = ABV positive
  • Only PCR positive = retest to confirm 4-6 weeks after first sample to see if seroconverted
  • Separate from others during this time
  • Only serology positive = presumed carriers, though with high titer may be positive
  • Retest PCR/serology in 4-6 weeks
  • If PDD present, single ABV test not helpful
  • PCR should be included in diagnostics for bird with GI/neuro signs, but is not a definitive “PDD test”
26
Q

What treatments exist for avian bornavirus?

Describe a flock management plan if a positive is detected.

Why is vaccination unlikely to be the answer for this disease?

A
  • Therapy
  • Antiviral treatment not successful to date
  • Amantadine, Ribavirin
  • Cyclosporine helpful in n=1
  • Robenacoxib with mycobacterial extract promising
  • Meloxicam had no beneficial effect in infected cockatiels
  • Flock management
  • Long periods of patency common in infected flock
  • Single birds may die over years
  • To clear flock, test all birds with direct/indirect tests
  • Separate birds into 3 groups based on results – positive, questionable, negative
  • Ethically, euthanasia of positive, non-clinical birds not recommended
  • Retest questionable/negative groups 4-6 weeks later
  • Continue testing and maintain separation until only negative birds remain
  • Only quarantined, tested birds can enter flock
  • Take eggs away from positive parents, disinfect, hand-raise and test
  • ABV negative eggs common form positive parents
  • If negative, can be given to foster parents
  • May need to rehome positive, non-clinical birds
  • Vaccination
  • Antibodies not protective and disease is immune-mediated
  • Difficult to develop vaccine
27
Q

Influenza viruses are in what family?

What are the four types?

What are the two proteins the subtypes are based on?

Which type affects the most species?

What is the difference between antigenic drift and antigenic shift?

What species are affected by the other three types?

A

Influenza viruses

  • Family Orthomyxoviridae
  • Enveloped, single-stranded, negative-sense, RNA virus
    • Segmented genomes consisting of 8 gene segments coding for 11 known proteins
    • Subdivided into types A, B, C, D
  • Type A (includes AIV)
    • Subtypes based on major antigenic proteins (hemagglutinin H/HA, neuraminidase N/NA)
      • 16 recognized HA and 9 recognized NA confirmations that occur in different combinations and provide basis for subtype nomenclature
    • May affect broad range of avian and mammalian species
      • Birds: widely distributed in waterfowl (specifically dabbling duck species) and shorebirds worldwide (natural hosts for AIV)
        • Direct spillover to poultry
      • Mammals: humans (seasonal flu), swine, horses, dogs, ferrets, bats, marine mammals
    • Responsible for outbreaks, epidemics, pandemics
    • Unpredictable, rapid rate of evolution & high ability to elude immune response
      • Antigenic drift – RNA polymerase has no proofreading function (substitutions result in error rate)
        • May contribute to ability to elude host immune response
        • Does not result in significant virulence changes
      • Antigenic shift – reassortment of gene segments when host co-infected with 2 different subtypes
        • Can radically change pathogenic potential
        • Potentially advances zoonotic potential; enhances ability to elude host immune response
  • Type B – express more restricted host range (humans, seals, experimentally ferrets)
    • Cause outbreaks/epidemics but not pandemics
  • Type C – largely confined to humans (also affect swine)
    • Cause outbreaks and localized epidemics
  • Type D – largely confined to cattle (also reported in swine)
    • Clinical significance is unknown at this time
28
Q

How do avian influenza viruses attach?

How are mammalian strains versus avian strains typically transmitted?

How is tissue tropism controlled?

What is required for the virus to invade a host cell?

What signs are caused by low path avian influenza?

What about high path avian influenza?

What hemagluttin subtypes are found in HPAI?

A

Pathogenesis

  • Virus attaches to host’s respiratory/GI epithelial cells’ sialic acid receptor via hemagglutinin protein
    • Mammalian strains are largely transmitted via resp routes
    • Avian strains are mainly transmitted via fecal-oral route in natural hosts
    • Tissue/species tropism is due to viral preference of glycoprotein receptor confirmation on epithelial cells
      • AIV’s prefer a-2,3 orientation (greater density in birds but also found in swine/human LRT)
      • Mammalian strains prefer a-2,6 orientation (greater density in mammals)
      • Swine have potential for infection by both mammalian/avian strains (mixing vessels)
        • Humans have this capability as well
  • Cleavage of hemagglutinin protein must occur in order to allow for cell entrance
    • Virulence implications
      • LPAI strains have single cleavage point; increases cell-type specificity (e.g. GI or respiratory only)
      • HPAI strains have multiple cleavage points; decreases cell-type specificity (can be systemic)

Pathogenicity

  • May have LPAI and HPAI strains with the same nomenclature (e.g H5N2)
  • LPAI – subclinical or mild clinical signs
    • Largely confined to GI tract in waterfowl (natural hosts; commensal infection)
    • Largely confined to respiratory tract in poultry
    • Some LPAI strains (H5, H7) are subject to mutation in poultry and can evolve into HPAI strains
  • HPAI – severe morbidity/mortality in poultry (aka fowl plague)
    • Restricted to H5 and H7 subtypes (not all H5 or H7 subtypes are HPAI)
    • No pathognomonic signs: ocular/nasal discharge, cough, dyspnea, head/sinus swelling, lethargy, hyporexia, wattle/comb cyanosis, incoordination, nervous signs, diarrhea, marked drop in egg production
      • May cause 100% flock mortality
    • Reportable to state/federal animal health authorities
    • Loss of billions of dollars of poultry yearly

HPAI Epidemiology

  • H5N1 detected in 1997 caused an epizootic that spread from Asia to Africa; caused human cases/fatalities
    • First HPAI that was found to infect waterfowl without causing significant morbidity/mortality
    • Able to spread long distances along migration routes
  • HPAI H5N8 (descended from H5N1) spread from Eurasia to North America in 2014
    • Reassembled into EA/NA HPAI H5N1 and H5N2; outbreaks in US domestic poultry 2014-2015
    • 2015: H5N2 caused largest cluster of HPAI outbreaks in domestic poultry in history of USA in Midwest
    • Not known to readily persist in within wild migratory waterfowl populations
29
Q

How is avian influenza diagnosed?

What samples are needed?

Serology is validated for what birds?

How is high or low pathogenicity determined?

A

Diagnosis

  • Agent identification
    • Samples of oropharyngeal/cloacal swabs, feces, tissues
    • Virus isolation (challenging for LPAI)
    • PCR – accurate and rapid results
  • Serology
    • Validated for poultry species
    • HPAI – birds may succumb to disease before seroconversion
    • ELISA
      • Preferred for veterinary diagnostic laboratories
      • Species-dependent or species-independent test formats
    • Agar gel immunodiffusion tests (AGIT)
      • Detect antibodies to conserved nucleocapsid/matrix antigens of influenza A viruses
      • Less reliable for non-poultry species
    • Hemagglutination inhibition (HI) assays
      • May lack sensitivity due to subtype specificity of hemagglutinin used
  • Determination of pathogenicity (LPAI vs HPAI)
    • Intravenous pathogenicity index
      • Inoculation of live susceptible chickens in virus-secure biocontainment lab
      • HPAI: mortality rate 75%+
    • Gene sequencing
      • HPAI: H5 or H7 genes with multiple cleavage sites common to all HPAI viruses
30
Q

What group of birds are commonly infected in the wild?

What group appears to be highly resistant?

How are avian influenza outbreaks prevented?

When is vaccination considered?

A

Other bird species

  • Occasional spillover to raptor/passerine species
    • Transmission: indirect (contaminated environment) or direct (consumption of tissues)
  • Columbiforms appear highly resistant to AIV
  • Psittacines
    • HPAI and LPAI have been documented (likely due to spillover from poultry/waterfowl)
    • Higher risk if exposed to infected high-risk species
    • Can cause serious morbidity/mortality
    • Vector capability is unknown

Prevention

  • Commercial poultry in US is subjected to rigorous surveillance for LPAI/HPAI (routine serologic/molecular testing)
  • Biosecurity: limiting direct/indirect contact with wild waterfowl populations/feces
    • Zoos: adequate management of water features that attract wildlife
    • House susceptible populations indoors
    • Install covering to prevent droppings from entering from above
    • Personnel protocols, PPE, procedures for movement/cleaning/disinfection of equipment
  • Vaccination – last resort
    • Strictly controlled in US due to impact of seropositive birds on interstate/international commerce
      • Important to identify vaccinated birds with microchip/tag/etc
    • High mutability complicates vaccination efforts
    • Killed and modified-live vaccines are available
    • LPAI – vaccination of turkeys in USA
    • HPAI – case-by-case basis in USA
    • Performance of vaccines in non-domesticated bird species is poorly understood
  • Depopulation if H5 or H7 subtype is detected

Zoonotic potential

  • HPAI: both H5 and H7 subtypes demonstrate zoonotic behavior
  • LPAI also exhibit zoonotic behavior
  • H7N9 (originated from China in 2013) causing ongoing infections
31
Q

A recent study evaluated the prevalence of avian influenza virus in wild birds in Poland.

How prevalent was the virus in wild birds?

Were any birds more positive than others?

Were there any seasonal patterns observed?

A

Świętoń, E., Wyrostek, K., Jóźwiak, M., Olszewska-Tomczyk, M., Domańska-Blicharz, K., Meissner, W., … & Śmietanka, K. (2017). Surveillance for avian influenza virus in wild birds in poland, 2008–15. Journal of wildlife diseases, 53(2), 330-338.

Abstract: We tested wild birds in Poland during 2008–15 for avian influenza virus (AIV). We took 10,312 swabs and feces samples from 6,314 live birds representing 12 orders and 84 bird species, mostly from orders Anseriformes and Charadriiformes, for testing and characterization by various PCR methods. From PCR-positive samples, we attempted to isolate and subtype the virus. The RNA of AIV was detected in 1.8% (95% confidence interval [CI], 1.5–2.1%) of birds represented by 48 Mallards (Anas platyrhynchos), 11 Mute Swans (Cygnus olor), 48 Common Teals (Anas crecca), three Black-headed Gulls (Chroicocephalus ridibundus), one Common Coot (Fulica atra), one Garganey (Spatula querquedula), and one unidentified bird species. Overall, the prevalence of AIV detection in Mallards and Mute Swans (the most frequently sampled species) was 2.0% (95% CI, 1.4–2.5%) and 0.5% (95% CI, 0.2–0.8%), respectively; the difference was statistically significant (P¼0.000). Hemagglutinin subtypes from H1 to H13 were identified, including H5 and H7 low pathogenic AIV subtypes. Mallards and Common Teals harbored the greatest diversity of subtypes. We observed seasonality of viral detection in Mallards, with higher AIV prevalence in late summer and autumn than in winter and spring. In addition, two peaks in AIV prevalence in summer (August) and autumn (November) were demonstrated for Mallards. The prevalence of AIV in Mute Swans did not show any statistically significant seasonal patterns.

32
Q

A recent study evaluated a recently developed ELISA for detection of avian influenza H5 subtype antibodies in vaccinated zoo birds.

What is the current gold standard for detecting antibodies to avian influenza?

How did this new test (the McNemar v2 test) perform against the gold standard?

What avian group had the best specificity and sensitivity?

Which avian groups had teh lowest specificity and sensitivity?

Did any avian groups show a poor vaccination response?

A

Jensen, T. H., Andersen, J. H., Hjulsager, C. K., Chriél, M., & Bertelsen, M. F. (2017). Evaluation of a commercial competitive enzyme-linked immunosorbent assay for detection of avian influenza virus subtype H5 antibodies in zoo birds. Journal of Zoo and Wildlife Medicine, 48(3), 882-885.

Abstract: The hemagglutination inhibition (HI) test is the current gold standard for detecting antibodies to avian influenza virus (AIV). Enzyme-linked immunosorbent assays (ELISAs) have been explored for use in poultry and certain wild bird species because of high efficiency and lower cost. This study compared a commercial ELISA for detection of AIV subtype H5 antibodies with HI test of 572 serum samples from zoo birds. There was no significant difference between the results of the two tests when statistically compared by a McNemar v2 test (P¼ 0.86) and assessment of j (j ¼ 0.87). With a specificity of 94.2 % (95 % confidence interval [CI], 0.92–0.97), a sensitivity of 93.9 % (95 % CI, 0.91–0.97), and an excellent correlation between the two tests, this ELISA can be recommended as an alternative to the HI test for preliminary screening of zoo bird sera for antibodies to AIV subtype H5.

  • Avian influenza subtypes H5 and H7 – risk for high pathogenicity and zoonotic potential
  • Study objective - evaluate the test characteristics of a commercial competitive ELISA against AIV subtype H5 antibodies pre and postvaccination, compared to classic HI testing of sera from exotic birds
  • Various bird species vaccinated twice with inactivated H5N9 AI vaccine 6 wk apart
    • Accipitriformes, Anseriformes, Charadriiformes, Ciconiiformes, Coraciiformes, Galliformes, Gruiformes, Pelecaniformes, Phoenicopteriformes, Psittaciformes, Sphenisciformes, Strigiformes, and Struthioniformes
    • Blood samples collected prior to 1st vaccination and 4–6 wk after 2nd vaccination
    • HI performed with H5N1, H5N2, and H5N7 antigens and competitive H5 antibody ELISA performed
  • ELISA - specificity 94.2 % and sensitivity 93.9 %
  • No statistically significant difference between the results of the ELISA and HI tests in this study
    • High agreement between the two tests
  • Best specificity and sensitivity was obtained for Galliformes
  • Lowest specificity and sensitivity in Sphenisciformes, followed by Phoenicopteriformes
  • Penguins, pelicans, guinea fowl, and Inca terns showed poor vaccination response

Conclusion – ELISA for detection of H5 AIV antibodies demonstrated a strong agreement with HI testing and a high sensitivity and specificity across many avian species

33
Q

How is West Nile transmitted?

What are the vectors?
What species are amplifying hosts?
What seasonal effects are there on transmission?

A

Fowler 10 Ch 76 - WNV

Transmission: complex cycle involving multiple species of mosquitoes and birds
* Primarily transmitted by Culex mosquitoes (C tarsalis, C pipiens)
* Other vectors: sand flies, ceratopogonids, ticks
* Passerines primary amplifier hosts (develop profound viremia that infect mosquitoes) especially house sparrow and American robin
* Antibodies in migratory birds suggest important in geographic dissemination
* Farmed American alligators also able to amplify WNV and serve as reservoir
* Drought was a more reliable predictor of human cases than temp or rain (promotes congregation of birds at water sources, increasing host/vector contact)
* Also reported through blood transfusion, organ transplant, percutaneous, transconjunctival, transplacentally
* Horizontal transmission in late summer (most common mechanism of spread)
* Maintained over winter by vertical transmission, suspected via breastfeeding

34
Q

Describe the host range of West Nile Virus.

What taxa are incidental or dead end hosts?

What are the typical clinical signs?

What avian taxa has the highest mortality rates?
- What are the typical clinical signs?
- What ophthalmic changes occur?
- What feather changes occur?

How are horses, humans, and alligators affected?

A

Host range
* Extremely broad host range across classes Mammalia, Reptilia, Aves, Amphibia, Arthropoda
* Incidental or dead-end hosts: significant M&M but do not amplify virus enough to contribute to further transmission (humans, horses, seals)
* CS: mostly neurologic +/- respiratory (nasal discharge, dyspnea), GI (reduced fecal output, vomiting, weight loss, diarrhea, anorexia), musculoskeletal (myalgia, arthralgia, stiffness), derm (rash), and ophthalmic.

Birds: most asymptomatic, variable mortality rates highest in corvids especially American crow (reported population declines)
* If CS present usually neuro +/- nasal discharge
* Wide ranges of exposure and susceptibility in raptor species
* Ophthalmic: exudative chorioretinal lesions, anterior uveitis, visual impairment
* Feather abnormalities in raptors: pinched-off feathers, constricted calamus tip, stunted growth, poor feather condition
* Often mortality without histo lesions likely due to acute fatal infection

Humans: 80% subclinical, can cause mild febrile illness
* 1% have West Nile Neuroinvasive Disease (WNND) - meningitis, encephalitis, or poliomyelitis (flaccid paralysis, eventual respiratory compromise), 9% mortality rate

Horses: CS none to death, neuro (ataxia, paresis, muscle fasciculations, recumbency, cranial nerve deficits, hyperexcitability, seizures) and fever most predominant

Farmed American alligators: stargazing, loss of neck control

35
Q

Describe the pathogenesis of West Nile Virus.

What lesions occur in avian species?
- What organs are particularly affected?

What lesions occur in horses?

What differentials should be considered:
- For mammals?
- For reptles?
- For birds?

A

Fowler 10 Ch 76 - WNV

Pathogenesis: transmission from mosquito saliva - replicates in dermal dendritic cells and keratinocytes - spreads to lymphatic system - establishes viremia - infects target organs (mechanism for CNS penetration not determined)
* Birds: CNS hemorrhage, lymphoplasmacytic and histiocytic myocarditis, granulomatous and lymphohistiocytic hepatitis, lymphocytic necrosis of spleen and kidney
– Targets renal system (proximal tubular necrosis and interstitial nephritis) and ocular system (disarray of retinal pigmented epithelial cells, pectenitis, choroiditis, retinitis, necrosis, optic neuritis)
* Horses: neuronal degeneration, CNS hemorrhage, perivascular cuffing, glial nodules, neuronophagia ,gliosis, myocarditis, renal hemorrhage, lymphoid atrophy

Ddx
* Mammals: CDV, rabies, arboviral encephalitides, epizootic hemorrhagic disease, CWD, bluetongue, small ruminant lentiviral encephalomyelitis, pseudorabies, louping ill
* Reptiles: mycoplasmosis
* Avian: heavy metal toxicity, fungal (asper), bacterial (mycobacteriosis), Borna virus

36
Q

What diagnostics are used to confirm West Nile INfection?
- How effective is serology?
- What is the use of PCR?
- What clinicopathologic changes are observed?

How is WNV treated?

How is it prevented?

A

Fowler 10 Ch 76 - WNV

Dx
* Serology: antibodies take a few days (if CS but seronegative retest in 10 days) and persist (IgM may indicate previous infection)
* Presence of IgM in CSF confirms infection bc usually do not cross BBB
* Antibodies to other flaviviruses may cross-react
* Plaque reduction neutralization test differentiates WNV antibodies from others
* RT-PCR: should not be used alone in vaccinated animals bc may detect killed WNV vaccine RNA
* Used to detect WNV RNA in nonvascular feathers from carcasses (60% sensitivity)
* IHC
* Clin path: humans leukocytosis and nonspecific inflammatory changes, birds reactive lymphocytes and heterophil toxicity
* CSF analysis: elevated protein and leukocytes
* Diagnostic imaging: not usually helpful, MRI may show thickening and enhancement of leptomeninges, cortical thinning and atrophy in brain after surviving infection

Treatment: supportive care

Prevention: reduce mosquitoes or contact with mosquitoes, vaccination
* Killed equine vaccine has variable seroconversion in different bird species but reports of rare clinical illness in vaccinated birds (off-label)
* Currently no registered vaccine against WNV in humans or wildlife